Showing session: reset
Realizing Patient Benefit: Four-Year Results From the SU2C Dream Teams
- Sort by:
- Browse by:
- Free
- Unknown permission
for presentation
SU2C Scientific Advisory Committee Chairperson, Opening Remarks
Phillip A. Sharp
MIT Koch Inst. for Integrative Cancer Res., Cambridge, MA, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Bringing Epigenetic Therapy to the Forefront of Cancer Management
Stephen B. Baylin
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
Julie R. Brahmer
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Combining a PI3K Inhibitor and PARP Inhibitor in High Grade Serous Ovarian Cancer and Triple Negative Breast Cancers
Gordon B. Mills
UT MD Anderson Cancer Ctr., Houston, TX, United States
Ursula Matulonis
Dana-Farber Cancer Inst., Boston, MA, United States
- Free
- Unknown permission
for presentation
Understanding Cancer Metastasis Through Circulating Tumor Cells
Mehmet Toner
Massachusetts General Hospital, Charlestown, MA, United States
Daniel A. Haber
Massachusetts General Hospital, Charlestown, MA, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
An Integrated Approach to Targeting Breast Cancer Molecular Subtypes and Their 'Resistance' Phenotypes
Dennis J. Slamon
UCLA David Geffen School of Medicine, Los Angeles, CA, United States
Joan S. Brugge
Harvard Medical School, Boston, MA, United States
- Permission not
granted for presentation
Cutting off the Fuel Supply: A New Approach to the Treatment of Pancreatic Cancer
Victor E. Velculescu
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States